Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer distinguished by the lack of expression of ER (estrogen receptors), PR (progesterone receptors), and HER2 (human epidermal growth factor receptor 2). This evidence concerns the gene ERBB2 and breast cancer.